tiprankstipranks
Trending News
More News >
Lisata Therapeutics (LSTA)
NASDAQ:LSTA
US Market

Lisata Therapeutics (LSTA) Financial Statements

Compare
1,049 Followers

Lisata Therapeutics Financial Overview

Lisata Therapeutics's market cap is currently $17.38M. The company's EPS TTM is $-0.49; its P/E ratio is -0.98; Lisata Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.51. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 1.00M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 1.00M$ 0.00$ 0.00$ 0.00$ -63.00K
Operating Income$ -22.41M$ -25.71M$ -57.60M$ -29.05M$ -19.14M
EBITDA$ -22.23M$ -25.52M$ -57.53M$ -29.00M$ -19.08M
Net Income$ -19.98M$ -20.84M$ -54.23M$ -27.47M$ -8.15M
Balance Sheet
Cash & Short-Term Investments$ 31.25M$ 50.53M$ 69.23M$ 94.97M$ 34.57M
Total Assets$ 35.00M$ 54.69M$ 73.03M$ 97.01M$ 36.00M
Total Debt$ 137.00K$ 168.00K$ 485.00K$ 714.00K$ 624.00K
Net Debt$ -16.07M$ -22.43M$ -31.67M$ -23.93M$ -15.89M
Total Liabilities$ 5.68M$ 6.80M$ 6.71M$ 5.01M$ 3.76M
Stockholders' Equity$ 29.57M$ 48.15M$ 66.58M$ 92.25M$ 32.50M
Cash Flow
Free Cash Flow$ -19.36M$ -20.03M$ -21.45M$ -22.30M$ -8.84M
Operating Cash Flow$ -19.36M$ -20.03M$ -21.17M$ -22.25M$ -8.82M
Investing Cash Flow$ 13.23M$ 10.10M$ 28.91M$ -54.90M$ -7.28M
Financing Cash Flow$ -206.00K$ 385.00K$ -224.00K$ 85.28M$ 18.58M
Currency in USD

Lisata Therapeutics Earnings and Revenue History

Lisata Therapeutics Debt to Assets

Lisata Therapeutics Cash Flow

Lisata Therapeutics Forecast EPS vs Actual EPS